Microscopic colitisK52.9 (Sonstige näher bezeichnete nichtinfektiöse Gastroenteritis und Kolitis)

Author:Prof. Dr. med. Guido Gerken

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Colitis microscopic; Collagen colitis; Collagenous colitis; Drug induced microscopic colitis; Lymphocytic colitis; microscopic colitis; Microscopic colitis

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

HistoryThis section has been translated automatically.

Lindström 1976; description of lymphocytic colitis by Lazenby 1989

DefinitionThis section has been translated automatically.

Microscopic colitis is a chronic inflammation of the mucous membrane of the colon, the cause of which is still not known and which is clinically associated with severe watery diarrhoea. With regard to the clinical leading symptom, these forms of disease are also summarised under the generic term "syndrome of watery diarrhoea". Microscopic colitis does not lead to macroscopically conspicuous (i.e. endoscopically visible) changes in the mucosa. However, it is defined by a characteristic histological finding. Thus, the clinical picture is only detectable in fine tissue.

ClassificationThis section has been translated automatically.

A distinction is made according to the histological picture (Olesen M et al. 2004):

  • lymphocytic colitis
  • collagenous colitis (collagenous colitis)

Occurrence/EpidemiologyThis section has been translated automatically.

In Europe, the lowest incidence (0.6/100,000) is reported for France and the highest (5.2/100,000) for Iceland (2/100,000). According to Swedish studies, the highest incidence rates are found in the group of women, > 60 years, with 26.9/ 100,000. Olesen et al. stated the incidence for Scandinavia at 4.4 per 100,000. For lymphocytic colitis, increasing incidence rates have been found in recent years according to the investigations of Pardi et al. Epidemiological studies from Sweden (Olesen M et al. 2016) and the USA (Pardi DS et al. 2007) unanimously show an increase in incidence rates in recent years. There is an increasing trend.

w:m=5:1.

EtiopathogenesisThis section has been translated automatically.

A multifactorial genesis is assumed; the triggering factors are various Drugs like NSAIDs, paroxetine, omeprazole, simvastatin. Bacterial genesis (detection of Yersinia antibodies)? Autoimmunological genesis (in 25% positive ANA titers)?

Furthermore, genetic factors (HLA determination) are discussed. Different mediators (TGF-beta, VEGF) were described in the context of the inflammatory reaction. The importance of luminal agents is understood by the fact that the formation of an ileostoma histologically leads to a significant reduction of the collagen band.

ManifestationThis section has been translated automatically.

The median age at diagnosis is 59 (48-70) years.

Clinical featuresThis section has been translated automatically.

The main symptom of microscopic colitis is watery diarrhoea (in 100% of cases). Furthermore:

  • nocturnal diarrhoea (27%)
  • Weight loss (42 %)
  • abdominal pain (41%)
  • Nausea (21%)
  • Meteorism (12 %)

Associated diseases: Sjögren's syndrome, Raynaud's syndrome, rheumatoid arthritis (seropositive/seronegative), psoriasis, sprue, thyroid dysfunction(hyper- or hypothyroidism) and diabetes mellitus have been described. About 10% of the persons were first or second degree relatives of patients with ulcerative colitis, Crohn's disease or celiac disease. In this respect, a genetic component must be discussed.

HistologyThis section has been translated automatically.

Collagenous colitis is characterized by a broad subepithelial collagen band (> 10 µm). Furthermore, an inflammatory infiltrate of the tunica propria consists of lymphocytes and plasma cells. In lymphocytic colitis there is a marked increase in intraepithelial T-lymphocytes (CD8+suppressor cells: > 20 intraepithelial lymphocytes per 100 epithelial cells) in the ceiling epithelium of the colonic mucosa. The ceiling epithelium itself is flattened and narrowed. Pathophysiology: The peculiarity of collagenous colitis is the excessive formation of a membrane (physiologically present in every human, but only a few micrometers thick) which normally separates the mucosal epithelial cells from the underlying layers of the intestinal wall. This membrane thickens; it then consists mainly of repair collagen, as occurs, for example, in scar formation.

Differential diagnosisThis section has been translated automatically.

Colitis of bacterial origin; lactose intolerance, irritable bowel syndrome of the diarrhoea type; Coeliac disease.

General therapyThis section has been translated automatically.

Probiotics: The effect of Lactobacillus acidophilus LA5 and Bifidobacterium animalis subspp. lactis BB12 was tested in 29 patients with collagenous colitis in a placebo-controlled study. However, there was no difference between the two treatment regimes.

E. coli extracts: Furthermore, the influence of E. coli extracts (bacterium Escherichia coli, strain Nissle 1917) was investigated in 14 patients with collagenous colitis. In 64 percent of the treated patients, a reduction of stool frequency by more than 50 percent was recorded. The results require further confirmation.

Symptomatic: As symptomatic antidiarrheal measures: loperamide, activated carbon.

Internal therapyThis section has been translated automatically.

First choice therapy is a combination therapy of glucocorticoids and 5-aminosalicylic acid (budesonide or prednisolone and mesalazine). In > 80 % of the patients an improvement of the symptoms occurs under budesonide (Olesen M et al. 2004).

Alternative: TNF-alpha antibodies (Infliximab, Adalimumab)

Alternative: Methotrexate: In analogy to Crohn's disease and ulcerative colitis, methotrexate was also used in patients who were refractory to therapy. In a small group, 14 of 19 patients treated in a retrospective case collection showed a good clinical response. Further studies on methotrexate are necessary.

Progression/forecastThis section has been translated automatically.

25% of cases, improvement. 75% of cases recur, sometimes with long symptom-free intervals.

NaturopathyThis section has been translated automatically.

Boswellia serrata (incense). The rationale for using Boswellia serrata is the inhibition of leukotriene synthesis. Madisch et al (2007) were able to prove the effect of incense therapy in a placebo-controlled study. With administration of 3 x 400 mg boswellia serrata extract 63.3 % of the patients were in clinical remission after 6 weeks. The difference to placebo (26.7 %) is statistically highly significant (p=0.04 (Madisch A et al. 2007).

LiteratureThis section has been translated automatically.

  1. Agnarsdottir MO et al (2002) Collagenous and lymphocytic colitis in Iceland. Dig. Dis. Sci. 47: 1122-1128
  2. Bohr J et al. (1995) Collagenous colitis in Örebro, Sweden, an epidemiological study 1984 - 1993. 37: 394-397
  3. Fernández-Banares F et al (1999) Incidence of collagenous and lymphocytic colitis - A 5-year population-based study. At J Gastroenterol 94: 418-423
  4. Gentile N et al (2018) Prevalence, Pathogenesis, Diagnosis, and Management of
  5. Microscopic colitis. Good Liver 12:227-235.
  6. Madisch A et al (2006) Clinical Course of collagenous colitis over a period of 10 years. C. Gastroenterol 44: 971 - 974
  7. Marshall JB et al (1995) Chronic, unexplained diarrhea: are biopsies necessary if colonoscopy is normal. Am. J. Gastroenterol 90: 372 - 376
  8. Miehlke S et al (2003) High prevalence of Yersinia IgG and IgA in patients with collagenous colitis. Gastroenterology 124: A144
  9. Olesen M et al (2004) Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Well 53: 536-541.
  10. Olesen M et al (2004) Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Well 53: 536-541
  11. Pardi DS et al (2007) The epidemiology of microscopic colitis: a population based study in Olmsted County, MN. Well 56: 504 - 508
  12. Thijs WJ et al (2005) Microscopic colitis: prevalence and distribution throughout the colon in patients with chronic diarrhea. Neth J Med 63: 137-140

Authors

Last updated on: 29.10.2020